ClinicalTrials.gov
ClinicalTrials.gov Menu

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01067287
Recruitment Status : Active, not recruiting
First Posted : February 11, 2010
Last Update Posted : May 11, 2018
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Rambam Health Care Campus
Gateway for Cancer Research
United States Department of Defense
Information provided by (Responsible Party):
David Avigan, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2022